絞り込み

16610

広告

運動は中高年から始めても遅くない (日経BP)

運動は総死亡、心血管疾患、癌のリスク低下に関係することが示されている。しかし、多くの研究では、ベースラインの運動量とアウトカムの関係を調べており、その後の生活習...

  1. 医学部受験「バブル」はひとまず終息しまし...
  2. 無給医、労基署による全大学病院の緊急点検...
  3. 転移性前立腺癌の治療はより早期に新規AR...
  4. しばしば誤嚥性肺炎の原因となる意外なあの...

ニュース一覧

「"Chapuis AG "[Author]」の検索結果

19件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.

The response to lymphodepletion impacts PFS in aggressive non-Hodgkin lymphoma patients treated with CD19 CAR-T cells.

Immunotherapy for skin cancer.

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR-T cells.

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.

Merkel Cell Carcinoma: Current United States Incidence and Projected Increases based on Changing Demographics.

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T cell function and therapy of murine leukemia.

Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8(+) T Cells In Vivo.

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.

T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies.

New Strategies in Engineering T-cell Receptor Gene-Modified T Cells to More Effectively Target Malignancies.

Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.

Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients.

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.

HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo.

Sort by
※並べ替えは表示に時間がかかります